J7176 HCPCS Level II code: Injection, human fibrinogen - chmt (fesilty), 1 mg
J7176 is the HCPCS code for “Injection, human fibrinogen - chmt (fesilty), 1 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J7176Injection, human fibrinogen - chmt (fesilty), 1 mg
Short description: Inj. fesilty, 1 mg
HCPCS · United States
Medicare details
The indicators CMS publishes with J7176 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care
- BETOS category
- Other drugs
- Added
- Jul 1, 2026
Where J7176 sits
- 1J codesDrugs administered other than orally
- 2Active code J7176Injection, human fibrinogen - chmt (fesilty), 1 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J7176 mean?
J7176 is the HCPCS code for “Injection, human fibrinogen - chmt (fesilty), 1 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J7176?
CMS lists J7176’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J7176
All J codesJ7170Injection, emicizumab-kxwh, 0.5 mgJ7171Injection, adamts13, recombinant-krhn, 10 iuJ7172Injection, marstacimab-hncq, 0.5 mgJ7173Injection, concizumab-mtci, 0.5 mgJ7174Injection, fitusiran, 0.04 mgJ7175Injection, factor x, (human), 1 i.u.J7177Injection, human fibrinogen concentrate (fibryga), 1 mgJ7178Injection, human fibrinogen concentrate, not otherwise specified, 1 mgJ7179Injection, von willebrand factor (recombinant), (vonvendi), 1 i.u. vwf:rcoJ7180Injection, factor xiii (antihemophilic factor, human), 1 i.u.J7181Injection, factor xiii a-subunit, (recombinant), per iuJ7182Injection, factor viii, (antihemophilic factor, recombinant), (novoeight), per iu